TP53 and inflammatory breast carcinoma: Frequent mutations of TP53, BRCA2, and homologous recombination (HR) genes [8, 9] and copy number alterations (gains and upregulation of MYC and MDM4, and losses of TP53 and RB1) were described in IBC [9].